237 related articles for article (PubMed ID: 15287949)
21. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
22. Von Willebrand factor antigen levels in Behçet disease.
Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
[TBL] [Abstract][Full Text] [Related]
23. Plasma thrombomodulin levels in patients with Behçet's disease.
Düzgün N; Ayaşlioğlu E; Tutkak H; Sahin M; Aydintuğ O; Olmez U
Rheumatol Int; 2003 May; 23(3):130-3. PubMed ID: 12739044
[TBL] [Abstract][Full Text] [Related]
24. [Blood coagulation and fibrinolysis in patients with Behçet's disease].
Fusegawa H; Ichikawa Y; Tanaka Y; Miyachi Y; Kawada T; Gondo K; Ikeda M; Shimizu H; Arimori S; Ando Y
Rinsho Byori; 1991 May; 39(5):509-16. PubMed ID: 2072574
[TBL] [Abstract][Full Text] [Related]
25. Coagulation and fibrinolytic activity in Behçet's disease.
Hampton KK; Chamberlain MA; Menon DK; Davies JA
Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
[TBL] [Abstract][Full Text] [Related]
26. [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].
Caserta L; Caserta R; Torella M; Perricone F; Nesti E; Sessa M; Tagliaferri A; De Francesco F; De Lucia D; Panariello S
Minerva Ginecol; 2004 Apr; 56(2):131-6. PubMed ID: 15258541
[TBL] [Abstract][Full Text] [Related]
27. An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities.
Toulon P; Perez P; Rapp J; Adda R
Thromb Haemost; 2007 Jul; 98(1):228-33. PubMed ID: 17598017
[TBL] [Abstract][Full Text] [Related]
28. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
[TBL] [Abstract][Full Text] [Related]
29. Basic parameters of thrombophilia in ocular Behçet disease with posterior segment involvement.
Citirik M; Haznedaroglu IC; Teberik K; Soykan E; Zilelioglu O
Br J Ophthalmol; 2009 Oct; 93(10):1382-6. PubMed ID: 19635722
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy.
Sarig G; Aberbach I; Schliamser L; Blumenfeld Z; Brenner B
Thromb Haemost; 2006 Nov; 96(5):578-83. PubMed ID: 17080213
[TBL] [Abstract][Full Text] [Related]
31. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
33. Erythrocyte deformability does not seem to be altered in Behçet's disease.
Simó M; Ricart JM; Santaolaria M; Ortí G; Vayá A
Clin Hemorheol Microcirc; 2007; 36(1):83-8. PubMed ID: 17211064
[TBL] [Abstract][Full Text] [Related]
34. Thrombophilia and venous thromboembolism: implications for testing.
Cohn DM; Roshani S; Middeldorp S
Semin Thromb Hemost; 2007 Sep; 33(6):573-81. PubMed ID: 17768689
[TBL] [Abstract][Full Text] [Related]
35. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
Kagawa H; Okubo S
Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
[TBL] [Abstract][Full Text] [Related]
36. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism.
Goldenberg N; Kahn SR; Solymoss S
J Clin Oncol; 2003 Nov; 21(22):4194-9. PubMed ID: 14615447
[TBL] [Abstract][Full Text] [Related]
37. Impaired binding of thrombin to thrombomodulin is associated with risk of deep vein thrombosis.
Suehisa E; Kawasaki T; Toku M; Hidaka Y
Thromb Res; 2008; 123(1):85-92. PubMed ID: 18590927
[TBL] [Abstract][Full Text] [Related]
38. [Physiologic blood coagulation studies in idiopathic arterial thrombosis].
Nowak-Göttl U; Kreuz WD; Krackhardt B; Freund H; Funk M; Linde R; Jacobi G; Scharrer I
Monatsschr Kinderheilkd; 1992 Mar; 140(3):183-7. PubMed ID: 1603102
[TBL] [Abstract][Full Text] [Related]
39. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
40. Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease.
Amoura Z; Dodé C; Hue S; Caillat-Zucman S; Bahram S; Delpech M; Grateau G; Wechsler B; Piette JC
Arthritis Rheum; 2005 Feb; 52(2):608-11. PubMed ID: 15692984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
